Natco Pharma Share Price Natco Pharma

579.75

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

580.40

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Feb-2020 - -
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve 1. Approval of the unaudited financial results, both on standalone and consolidated basis for the quarter ended 31st December, 2019 and related matters. 2. To consider third Interim Dividend, if any, for the financial year 2019-20 and related matters etc. Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 12, 2020, inter alia, to consider the following items of business: 1. Approval of the unaudited financial results, both on standalone and consolidated basis for the quarter ended December 31, 2019 and related matters. 2. To consider third Interim Dividend, if any, for the financial year 2019-20 and related matters etc. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time TRADING WINDOW for dealing in the securities of the Company by the Employee(s) and their immediate relatives will be closed from February 04, 2020 to February 14, 2020 (both days inclusive). Trading window will be re-opened on February 17, 2020. The Board of Directors of the Company at their meeting held on 12/2/2020 have declared 3rd Interim Dividend of Rs.3.50 per Equity share of Rs.2/- each for the FY 2019-2020 Outcome of Board Meeting (As Per BSE Announcement Dated on 12.02.2020)
Board Meeting - 04-Nov-2019 - -
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2019. With reference to the earlier announcement dated November 04, 2019 regarding Board Meeting Intimation for Results, Natco Pharma Ltd has now informed BSE that the Board may consider declaration of 2nd Interim Divided, if any, for the Financial Year 2019-2020 at the Board Meeting scheduled to be held on November 12, 2019. (As Per BSE Announcement Dated on 05-11-2019)
Board Meeting - 31-Jul-2019 - -
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve To consider un-audited results for the quarter ended June 30, 2019 and interim dividend for the FY 19-20 Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on August 09, 2019, inter alia, have considered and approved the following along with other items of business:- Declaration of interim dividend of Rs. 1.25 ps. per equity share of Rs. 2/- each for the financial year 2019-20. The said interim dividend pay-by-date is on or before August 29, 2019.(As Per BSE Announcement Dated on 8/9/2019 2:43:21 PM) Intimation of completion of Investment (As Per BSE Announcement Dated 03.12.2019)